Amplicon details |
||
Amplicon: |
215 bp | |
1 ctcaccttgc tcctgccgag aaagtatcca tcatggctga tgcaatgcgg 51 cggctgcata cgcttgatcc ggctacctgc ccattcgacc accaagcgaa 101 acatcgcatc gagcgagcac gtactcggat ggaagccggt cttgtcgatc 151 aggatgatct ggacgaagag catcaggggc tcgcgccagc cgaactgttc 201 gccaggctca aggcg |
Record ID | Database | Record description | Record length | Taxon | Method | Amplicon size | Match details |
---|---|---|---|---|---|---|---|
DI213895.1 | emblrelpat | KR 1020110015422-A/21: PRODUCTION P... | 6527 bp | artificial sequences | QL-ELE-00-002 | 215 bp | View |
DI213896.1 | emblrelpat | KR 1020110015422-A/22: PRODUCTION P... | 8257 bp | artificial sequences | QL-ELE-00-002 | 215 bp | View |
DI213897.1 | emblrelpat | KR 1020110015422-A/23: PRODUCTION P... | 8439 bp | artificial sequences | QL-ELE-00-002 | 215 bp | View |
DI213898.1 | emblrelpat | KR 1020110015422-A/24: PRODUCTION P... | 7990 bp | artificial sequences | QL-ELE-00-002 | 215 bp | View |
DI215392.1 | emblrelpat | KR 1020110022625-A/2: RECOMBINANT C... | 7296 bp | artificial sequences | QL-ELE-00-002 | 215 bp | View |
DI215688.1 | emblrelpat | KR 1020110053314-A/9: MENINGOCOCCAL... | 5759 bp | artificial sequences | QL-ELE-00-002 | 215 bp | View |
DI216044.1 | emblrelpat | KR 1020120082673-A/18: Method for t... | 5900 bp | artificial sequences | QL-ELE-00-002 | 215 bp | View |
DI223600.1 | emblrelpat | KR 1020110031969-A/28: THERAPEUTIC ... | 6165 bp | artificial sequences | QL-ELE-00-002 | 215 bp | View |
DI231001.1 | emblrelpat | KR 1020110091567-A/40: Production o... | 2571 bp | artificial sequences | QL-ELE-00-002 | 215 bp | View |
DI231103.1 | emblrelpat | KR 1020110096555-A/39: Manufacturin... | 1568 bp | artificial sequences | QL-ELE-00-002 | 215 bp | View |
DI231104.1 | emblrelpat | KR 1020110096555-A/40: Manufacturin... | 2571 bp | artificial sequences | QL-ELE-00-002 | 215 bp | View |
DI231621.1 | emblrelpat | KR 1020110096579-A/8: Oncolytic ade... | 38303 bp | artificial sequences | QL-ELE-00-002 | 215 bp | View |
DI231623.1 | emblrelpat | KR 1020110096579-A/10: Oncolytic ad... | 38366 bp | artificial sequences | QL-ELE-00-002 | 215 bp | View |
DI231890.1 | emblrelpat | KR 1020110119650-A/2: Protein subst... | 6078 bp | artificial sequences | QL-ELE-00-002 | 215 bp | View |
DI231958.1 | emblrelpat | KR 1020110106901-A/7: IMPROVED VACC... | 3824 bp | artificial sequences | QL-ELE-00-002 | 215 bp | View |
DI233232.1 | emblrelpat | KR 1020110125246-A/27: A PKN3/RHOC ... | 5446 bp | artificial sequences | QL-ELE-00-002 | 215 bp | View |
DI233287.1 | emblrelpat | KR 1020110127690-A/5: NOVEL MICROBI... | 7112 bp | artificial sequences | QL-ELE-00-002 | 215 bp | View |
DI234700.1 | emblrelpat | KR 1020120001757-A/51: Cells Useful... | 7570 bp | artificial sequences | QL-ELE-00-002 | 215 bp | View |
DI237505.1 | emblrelpat | KR 1020120064656-A/37: trans- splic... | 8793 bp | artificial sequences | QL-ELE-00-002 | 215 bp | View |
DI237506.1 | emblrelpat | KR 1020120064656-A/38: trans- splic... | 9939 bp | artificial sequences | QL-ELE-00-002 | 215 bp | View |
Related publications:
Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101.
Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.